Archives

  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Tin Mesoporphyrin IX (Chloride): Potent Heme Oxygenase In...

    2026-01-08

    Tin Mesoporphyrin IX (Chloride): Potent Heme Oxygenase Inhibitor in Advanced Metabolic and Viral Research

    Introduction: Principle and Research Rationale

    Understanding the intricacies of heme catabolism and its regulatory enzymes is central to unraveling the pathophysiology of metabolic, inflammatory, and infectious diseases. Tin Mesoporphyrin IX (chloride)—a potent, competitive inhibitor of heme oxygenase (HO)—has established itself as a gold-standard tool in dissecting heme oxygenase signaling pathways. With a remarkable Ki of 14 nM, this compound exhibits robust inhibition of HO activity both in vitro and in vivo, making it indispensable for researchers focusing on metabolic disease research, insulin resistance study, and metaflammation research.

    Heme oxygenase, particularly the inducible isoform HO-1, catalyzes the degradation of heme into biliverdin, ferrous iron, and carbon monoxide—key events influencing oxidative stress, immune modulation, and cellular signaling. In the landscape of viral research, for example, upregulation of HO-1 has been linked to antiviral effects via modulation of reactive oxygen species (ROS) and viral protein folding, as highlighted in recent studies on hepatitis B virus (HBV) replication (Koyaweda et al., 2026).

    APExBIO provides Tin Mesoporphyrin IX (chloride) (SKU: C5606), a crystalline solid with high solubility in DMSO and dimethyl formamide, ensuring experimental flexibility and reproducibility.

    Optimized Experimental Workflows: Step-by-Step Protocol Guidance

    1. Preparation and Handling

    • Stock Solution: Dissolve Tin Mesoporphyrin IX (chloride) at up to 0.5 mg/ml in DMSO or 1 mg/ml in dimethyl formamide. Filter-sterilize if required.
    • Aliquot and Storage: Prepare single-use aliquots to minimize freeze-thaw cycles; store at -20°C for optimal stability. Use solutions within a short time frame (preferably within a week) for maximal activity.
    • Light Sensitivity: Protect from prolonged light exposure to prevent photodegradation.

    2. In Vitro Heme Oxygenase Activity Assay

    1. Cell Preparation: Culture target cell lines (e.g., hepatocytes, macrophages, or relevant viral infection models) under standard conditions.
    2. Treatment: Add Tin Mesoporphyrin IX (chloride) to experimental groups at desired concentrations (typically 1–100 nM for potent HO inhibition; titrate as needed).
    3. Stimulation (Optional): Induce HO-1 expression using agents such as hemin or oxidative stress inducers for mechanistic studies.
    4. Assay: Assess HO activity by measuring conversion of heme to biliverdin (via spectrophotometric or fluorometric methods) or by quantifying bilirubin production.
    5. Controls: Include vehicle, non-inhibitor, and positive control inhibitors for robust comparative analysis.

    3. In Vivo Protocols for Metabolic and Viral Models

    • Dosing: In animal studies, administer Tin Mesoporphyrin IX (chloride) at 1 pmol/kg body weight via appropriate routes (e.g., intraperitoneal or intravenous injection).
    • Sampling: Collect tissue samples (liver, kidney, spleen) at defined time points to measure residual HO activity and downstream metabolites (e.g., serum bilirubin in hyperbilirubinemia models).
    • Endpoint Analysis: Combine biochemical assays with qPCR, immunoblotting, or histological analysis to elucidate pathway-specific effects.

    Advanced Applications and Comparative Advantages

    Tin Mesoporphyrin IX (chloride) is uniquely positioned for applied research in several domains:

    • Metabolic Disease Models: By blocking HO-mediated heme catabolism, researchers can probe the interplay between heme metabolism and insulin resistance, as well as investigate links to non-alcoholic fatty liver disease and metaflammation. The ability to modulate HO activity with nanomolar precision supports dose-dependent mechanistic studies.
    • Viral Pathogenesis: Recent findings, such as those by Koyaweda et al., 2026, demonstrate the utility of heme oxygenase modulators in unraveling viral life cycles. For example, upregulation of HO-1 was shown to impair HBV replication through ROS modulation and disruption of viral protein assembly. Conversely, using Tin Mesoporphyrin IX (chloride) to inhibit HO activity allows researchers to dissect the specific contributions of HO-1 in viral defense mechanisms, protein folding, and morphogenesis.
    • Inflammatory and Oxidative Stress Research: The competitive inhibition of HO-1 provides a powerful approach to differentiate between heme oxygenase-dependent and -independent pathways in models of chronic inflammation and oxidative stress.

    This advanced inhibitor is consistently recognized as a benchmark compound, as highlighted in Strategic Deployment of Tin Mesoporphyrin IX (Chloride), which discusses its role in precision medicine and translational pipelines. For researchers needing a factual, structured overview of its properties and mechanistic insights, the article Tin Mesoporphyrin IX (chloride): Potent Heme Oxygenase Inhibitor offers a solid foundation, while Strategic Heme Oxygenase Inhibition extends the discussion to future therapeutic innovation.

    Troubleshooting and Optimization Tips

    Common Pitfalls and Solutions

    • Poor Solubility: If precipitation occurs, ensure complete dissolution in DMSO/dimethyl formamide before dilution into aqueous buffers. Use gentle heating (≤37°C) and avoid sonication, which may degrade the compound.
    • Loss of Inhibitory Activity: Repeated freeze-thaw cycles or prolonged storage of stock solutions can compromise activity. Prepare fresh aliquots and avoid repeated thawing.
    • Off-Target Effects: At higher concentrations, non-specific effects may emerge. Always perform concentration-response experiments and include appropriate controls to validate specificity.
    • Assay Interference: The compound’s deep color may interfere with optical assays. Where possible, use endpoint measurements or validate alternative readout wavelengths.
    • In Vivo Dosing Consistency: For animal studies, rigorously calibrate injection volumes and mixing to ensure reproducible bioavailability and tissue distribution.
    • Photostability: Protect solutions from light, especially during prolonged incubations or storage, to maintain potency.

    For more troubleshooting insights, the article Potent Heme Oxygenase Inhibitors in Experimental Research contrasts Tin Mesoporphyrin IX (chloride) with other HO inhibitors, offering comparative stability and specificity data.

    Data-Driven Performance and Insights

    • Nanomolar Affinity: The compound’s Ki of 14 nM enables precise titration and robust inhibition in cellular and animal models.
    • Extended Inhibition: In animal models, a single dose (1 pmol/kg) suffices to suppress hepatic, renal, and splenic HO activity for extended periods, with measurable reductions in serum bilirubin—critical for neonatal hyperbilirubinemia studies.
    • Mechanistic Dissection: Enables clear differentiation of HO-1-mediated effects in metabolic and viral processes, as evidenced by the modulation of ROS and viral protein folding in HBV models (Koyaweda et al., 2026).

    Future Outlook: Expanding the Frontiers of Heme Oxygenase Research

    The strategic deployment of Tin Mesoporphyrin IX (chloride) is poised to drive the next wave of discoveries in heme oxygenase signaling pathway research. As evidence mounts for the role of HO-1 in viral pathogenesis, metabolic syndrome, and chronic inflammatory states, researchers are increasingly leveraging this tool to unravel new therapeutic targets and refine disease models. The reference study by Koyaweda et al., 2026 exemplifies the power of dissecting HO-1’s role in viral replication and ROS modulation, opening doors to antiviral and immunomodulatory strategies.

    As clinical translation advances, the demand for high-quality, validated tools is paramount. APExBIO remains a trusted supplier of Tin Mesoporphyrin IX (chloride), supporting the global research community with rigorously characterized and batch-tested products. Researchers are encouraged to integrate this compound into multi-omics pipelines, CRISPR-based editing workflows, and high-throughput screening platforms for maximal impact.

    Conclusion

    Tin Mesoporphyrin IX (chloride) is an essential reagent for modern heme oxygenase research, offering unmatched potency, specificity, and versatility. By following best practices in experimental design and troubleshooting, and leveraging cutting-edge insights from recent literature, investigators can confidently advance the frontiers of metabolic and viral pathogenesis research. For further details or to source high-purity material, consult APExBIO’s official product page for Tin Mesoporphyrin IX (chloride).